Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25218906

Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2014 Oct
First author
Liu JF

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Oct;15(11):1179-81. doi: 10.1016/S1470-2045(14)70421-8.
    note
    Source null
    related pmid
    25218905
    relationship
    Comment in

Authors and identifiers

  1. name
    Liu JF
    type
    Author
  2. name
    Barry WT
    type
    Author
  3. name
    Birrer M
    type
    Author
  4. name
    Lee JM
    type
    Author
  5. name
    Buckanovich RJ
    type
    Author
  6. name
    Fleming GF
    type
    Author
  7. name
    Rimel B
    type
    Author
  8. name
    Buss MK
    type
    Author
  9. name
    Nattam S
    type
    Author
  10. name
    Hurteau J
    type
    Author
  11. name
    Luo W
    type
    Author
  12. name
    Quy P
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Liu JF
    type
    Author
  2. name
    Barry WT
    type
    Author
  3. name
    Birrer M
    type
    Author
  4. name
    Lee JM
    type
    Author
  5. name
    Buckanovich RJ
    type
    Author
  6. name
    Fleming GF
    type
    Author
  7. name
    Rimel B
    type
    Author
  8. name
    Buss MK
    type
    Author
  9. name
    Nattam S
    type
    Author
  10. name
    Hurteau J
    type
    Author
  11. name
    Luo W
    type
    Author
  12. name
    Quy P
    type
    Author
bibliography ids
  1. nci-bib-53fffb085c34d4ae46d98666
book metadata
content sha256
a86031d4e5e01565c1c7684b935fed56e8b62618174f447c7cc7946531c948d6
document type
citation
dois
  1. 10.1016/S1470-2045(14)70391-2
electronic publication date
display
2014 Sep 10
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:25218906
immutable id
pubmed:25218906@a86031d4e5e01565c1c7684b935fed56e8b62618174f447c7cc7946531c948d6
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
11
name
The Lancet. Oncology
nlm unique id
100957246
pages
1207-14
volume
15
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Oct;15(11):1179-81. doi: 10.1016/S1470-2045(14)70421-8.
    note
    Source null
    related pmid
    25218905
    relationship
    Comment in
outcomes validated
false
pmid
25218906
provenance
batch id
69903be8ceab8801c81a
provider
NCBI PubMed ESummary
record sha256
d98fb3f4139770b4005df17d20d338dca932aacae87e8f156653fc1895c8d542
response sha256
1e367491c3c459a93f45b3db99ca1f9293ed2287c48bdf758bb088ffcd7c96eb
retrieved at
2026-09-09T23:47:05.208886+00:00
publication date
display
2014 Oct
precision
month
year
2014
publication types
  1. Clinical Trial, Phase II
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, N.I.H., Extramural
  7. Research Support, N.I.H., Intramural
  8. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25218906/
title
Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study.

Preserved source evidence · Not medical advice